Fisher Funds Management LTD Acquires 13,390 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Fisher Funds Management LTD boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 85,119 shares of the company's stock after purchasing an additional 13,390 shares during the period. Fisher Funds Management LTD's holdings in HCA Healthcare were worth $29,413,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of HCA. Sanders Capital LLC increased its position in HCA Healthcare by 1.0% in the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after acquiring an additional 116,826 shares during the period. First Eagle Investment Management LLC increased its position in shares of HCA Healthcare by 0.5% during the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock valued at $1,351,830,000 after purchasing an additional 23,177 shares during the period. Geode Capital Management LLC boosted its stake in shares of HCA Healthcare by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock worth $1,159,882,000 after acquiring an additional 50,321 shares in the last quarter. Capital World Investors boosted its stake in shares of HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock worth $878,975,000 after acquiring an additional 19,121 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of HCA Healthcare in the fourth quarter worth $840,286,000. Institutional investors own 62.73% of the company's stock.

Insider Activity at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HCA. Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Barclays set a $416.00 target price on HCA Healthcare and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $395.71.

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $0.63 during trading hours on Monday, hitting $377.21. The company had a trading volume of 153,905 shares, compared to its average volume of 1,458,409. The firm has a market cap of $90.75 billion, a PE ratio of 16.78, a PEG ratio of 1.30 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The firm has a 50-day moving average of $371.55 and a 200 day moving average of $339.67.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. During the same period in the prior year, the firm earned $5.36 EPS. The business's revenue was up 5.7% on a year-over-year basis. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were issued a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.